Dr. Arora is investigating the natural history of disease progression in both upper and lower extremities using functional tests and magnetic resonance imaging in Duchenne muscular dystrophy (DMD) patients. While DMD is an incurable disease, Dr. Arora's reserach will make it possible to identify appropriate age groups to evaluate the efficacy of therapeutic drugs in onging clinical trials. Dr. Arora is involved in developing a protocol for an exercise study in mice using phosphorous magnetic resonance spectroscopy, where she is measuring the energetics in healthy controls with the long term goal of moving the protocol to DMD patients. This would help in early detection of the disease in DMD patients. Dr. Arora earned her PhD in Rehabilitation Science from the University of Florida. She has been recognized for her exceptional science communication skills, including "Best Poster Award in Research Section" at the American Physical Therapy Association–Combined Sections Meeting, Anaheim, CA.
Dr. Banerjee is elucidating the altered cellular dynamics elicited by hyperthermia. Understanding the cross talk between cancer cells exposed to hyperthermia and immune cells will aid in the development of improved cancer immunostimulatory therapeutic strategies and regimens. Dr. Banerjee earned her PhD in Cancer Nanotherapeutics from the School of Medical Science and Technology at the Indian Institute of Technology in Kharagpur, India. She has been awarded the Junior Research Fellowship (2009) and Senior Research Fellowship (2012) by the University Grants Commission. Dr. Banerjee's journal article entitled “Second generation liposomal cancer therapeutics: transition from laboratory” has been acknowledged as one of the top 25 most downloaded articles published in the International Journal of Pharmaceutics from January-June, 2013.
Dr. Canton is reseraching the gut physiology of the agricultural pest Nezara viridula, the southern green stink bug, in order to gain insights that will help develop new and better strategies for its control in crop fields. He earned his PhD in Biochemistry from the National Autonomous University of Mexico. Dr. Canton has developed a strong research career in insect control with multiple publications, as well as being co-founder and member of a science communication and outreach NGO. This combination is critical in bridging the gap between academia and those who would benefit from scientific applications. Right Photo: N. viridula, the southern green stink bug.
Dr. Crofts research is focused on understanding how intracellular inclusions that build up in the brain in neurodegenerative diseases such as Alzheimer’s disease and Parkinson’s disease can cause whole brain organ failure. Dr. Croft has developed novel methods that use organotypic brain slice cultures and recombinant adeno-associated viruses to model these diseases in a dish. By using these unique methods, Dr. Croft can examine at a molecular and cellular level how these intracellular inclusions can drive neurodegeneration and cellular dysfunction and how we can most appropriately therapeutically target them. Dr. Croft earned her PhD in Neuroscience from King's College London, United Kingdom, where she was selected as a finalist to present her research to politicians and policy makers in the UK advocating for increased research funding for dementia. Dr. Croft has recently been awarded a 2 year post-doctoral fellowship from the Brightfocus Foundation to begin her path to academic independence.Learn More about Dr. Croft's Research
Dr. Sarah Kim is a senior postdoctoral associate at the University of Florida’s Center for Pharmacometrics and Systems Pharmacology in Lake Nona (Orlando), working under the supervision by Dr. Stephan Schmidt, Dr. Mirjam Trame and Dr. Larry Lesko. Her current research projects focus on: 1) systems pharmacology modeling to improve drug safety, for which she received the David Goldstein Trainee Award from the American Society for Clinical Pharmacology and Therapeutics (ASCPT) in 2017 and two Presidential Trainee Awards from ASCPT in 2017 and 2018, 2) population pharmacokinetic/pharmacodynamic (PK/PD) modeling and simulations to evaluate the impact of potential bioinequivalence on PD, and 3) physiologically-based absorption pharmacokinetic (PBA-PK) modeling to evaluate the impact of drug formulation and system-specific properties on PK. She also serves as a reviewer for the European Journal of Pharmaceutical Sciences, and was selected as one of the most productive reviewers in 2017. Dr. Kim earned her PhD in Biomathematics in the Department of Mathematics at Florida State University, USA.
Dr. Kuwar is engineering Bacillus thunringensis (Bt) derived proteins and toxins to increase their efficacy against insect pests.
He earned his PhD in Molecular Biology in the Department of Entomology at the Max Planck Institute for Chemical Ecology, Jena, Germany.
Dr. Kuwar is an International Max Planck Research Scholar. He has beed regonized for his scientific communications, including a best poster award, and has given talks at a variety of professional conferences and meetings. He actively contributes to UF and his field as a teacher and through outreach.
Dr. Nguyen conducts research to determine and implement advanced stabilization techniques and time marching schemes for the deliverable PSAAP-II code CMT-Nek (NNSA’s Predictive Science Academic Alliance Program II ), as well as integrate the finding of CS and exascale behavioral emulation into this code. He earned his PhD from the Department of Civil, Environmental and Mechanical Engineering at the University of Trento, Italy. Right Photo: The falling droplet with a HLLEM Riemann solver.Learn more about Dr. Nguyen's research